Antagonist Of The Fibroblast Growth Factor Receptor 3 (Fgfr3) For Use In The Treatment Or The Prevention Of Skeletal Disorders Linked With Abnormal Activation Of Fgfr3 - EP2790718
EP2790718
- Application Number
- EP12799204A
- Filing Date
- Dec 12, 2012
- Status
- No Opposition Filed Within Time Limit
- Dec 14, 2018
- Grant Date
- Feb 7, 2018
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP2790718B1 was granted to Assistance Publique Hpitaux DE Paris on Feb 7, 2018 following the initial filing on Dec 12, 2012 under the application number EP12799204A . The current legal status of the patent is No Opposition Filed Within Time Limit.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents